Document is current
Any future updates will be listed below
-
Authors
Falster, Casper https://orcid.org/0000-0002-0389-5386
Egholm, Gro https://orcid.org/0000-0001-7618-7842
Jacobsen, Niels https://orcid.org/0000-0001-6189-2290
Poulsen, Mikael K.
Posth, Stefan https://orcid.org/0000-0002-4325-038X
Møller, Jacob E. https://orcid.org/0000-0003-2873-5845
Brabrand, Mikkel https://orcid.org/0000-0002-3340-8251
Laursen, Christian B. https://orcid.org/0000-0001-6382-9906
-
Funding
Funding for this research was provided by:
Odense Universitetshospital
Syddansk Universitet
Snedkermester Sophus Jacobsen og Hustru Astrid Jacobsens Fond
- License Information
-
More Information
Article History
Received: 24 June 2022
Accepted: 4 August 2022
First Online: 17 September 2022
Declarations
:
: Casper Falster has received personal fees from AstraZenica outside the submitted work. Gro Egholm has received personal fees from AstraZenica, Bayer and Bristol Myers Squibb outside the submitted work. Prof Jacob E Møller has received grants and personal fees from Abiomed, personal fees from Novartis, Orion Pharma, and Boeinger Ingelheim outside the submitted work. All remaining authors declare no competing interests.
: Permission for initiation of the study was granted by The Regional Committees on Health Research Ethics of Southern Denmark. The study has therefore been performed in accordance with the ethical standards laid down in the Helsinki Declaration of 1975 and its late amendments.
: Informed consent was obtained from all individual participants included in the study.
